PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 14 | -94.9% | 0.00% | – |
| Q3 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 275 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 275 | -79.2% | 0.00% | – |
| Q3 2021 | $9,000 | -98.3% | 1,323 | -97.7% | 0.00% | -100.0% |
| Q2 2021 | $524,000 | +52300.0% | 57,102 | +36270.7% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 157 | +58.6% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 99 | -39.3% | 0.00% | – |
| Q1 2020 | $1,000 | -98.1% | 163 | -96.7% | 0.00% | -100.0% |
| Q3 2019 | $53,000 | -13.1% | 4,900 | +2.1% | 0.00% | 0.0% |
| Q2 2019 | $61,000 | -67.2% | 4,800 | 0.0% | 0.00% | -66.7% |
| Q1 2019 | $186,000 | +89.8% | 4,800 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $98,000 | – | 4,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,300,000 | $12,636,000 | 2.61% |
| AIGH Capital Management LLC | 964,590 | $9,376,000 | 1.97% |
| Worth Venture Partners, LLC | 226,758 | $2,204,000 | 1.07% |
| Camber Capital Management LP | 2,555,000 | $24,835,000 | 0.85% |
| Palo Alto Investors LP | 1,392,997 | $13,540,000 | 0.77% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,769,795 | $36,642,000 | 0.77% |
| GLOBEFLEX CAPITAL L P | 428,680 | $4,167,000 | 0.76% |
| Zebra Capital Management LLC | 34,243 | $333,000 | 0.37% |
| Sofinnova Investments, Inc. | 344,917 | $3,353,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 605,792 | $5,888,000 | 0.19% |